Phage-induced protection against lethal bacterial reinfection

Area of Science:

• Microbiology
• Immunology
• Virology

Background:

• Antimicrobial resistance (AMR) necessitates novel therapeutic strategies.
• Bacteriophages (phages) are viruses targeting bacteria, explored as an alternative to antibiotics.
• Current phage therapy focuses on the lytic (bacteria-killing) activity of phages.

Purpose of the Study:

• To investigate potential therapeutic benefits of phage therapy beyond bacterial lysis.
• To characterize a novel long-term protective effect observed in phage-treated animals.
• To elucidate the mechanism behind this extended protection against bacterial reinfection.

Main Methods:

• Animal models of bacterial infection treated with phage therapy.
• Assessment of protection against primary and secondary lethal infections.
• In vitro experiments with phage-lysed bacteria and immune cell stimulation.

Main Results:

• Phage therapy provided significant long-term protection against lethal reinfection, independent of ongoing phage administration.
• This protection reduced bacterial burden by a billion-fold compared to controls.
• The effect requires initial phage lysis but is not solely due to phage presence or resistant bacteria.

Conclusions:

• Phage therapy exhibits a dual-action effect: immediate bacterial lysis and a subsequent long-term protective immune response.
• This protective effect suggests a therapeutic-vaccination-like mechanism.
• Certain phages may induce adaptive host immunity following bacterial lysis, offering sustained protection.